Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade - PubMed (original) (raw)

Review

Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade

Luca Perico et al. Nephron. 2020.

Abstract

Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.

Keywords: Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; Renal and cardiac side effects; SARS-CoV-2; Severe acute respiratory syndrome coronavirus.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1

The zoonotic origins of coronaviruses. In nature, several animal species act as natural host reservoirs for viruses. Coronaviruses are commonly found in different bat species. However, intermediate hosts are thought to be necessary for coronaviruses to move from the primary reservoir species into humans. Coronaviruses inducing the outbreak of Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) were originally bat viruses that spread to an intermediate animal (civet cat and camel, respectively), which then exposed humans to the viruses. Genetic analysis of the coronavirus causing the novel COVID-19 outbreak (SARS-CoV-2) recently showed that their closest genetic relatives appear to be bat coronaviruses, with the role of intermediate species possibly played by the pangolin, although with some conflicting results. Recent studies shown that some bat coronaviruses can infect human cells without passing through an intermediate host. Total number of COVID-19 cases and deaths are relative to the available data on March 15, 2020.

Comment in

Clinical Trials during the SARS-CoV-2 Pandemic.
Warnock DG. Warnock DG. Nephron. 2020;144(5):248-250. doi: 10.1159/000507582. Epub 2020 Apr 14. Nephron. 2020. PMID: 32289798 Free PMC article. No abstract available.
Comment on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade".
Cure E, Cumhur Cure M. Cure E, et al. Nephron. 2020;144(5):251-252. doi: 10.1159/000507786. Epub 2020 Apr 20. Nephron. 2020. PMID: 32311696 Free PMC article. No abstract available.

Cited by

Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases.
Liu X, Wang X, Zhang P, Fang Y, Liu Y, Ding Y, Zhang W. Liu X, et al. Front Immunol. 2023 Nov 1;14:1266792. doi: 10.3389/fimmu.2023.1266792. eCollection 2023. Front Immunol. 2023. PMID: 38022571 Free PMC article. Review.
Pathomorphological Features of the Novel Coronavirus Disease in Patients with Systemic Amyloidosis.
Mikhaleva L, Gioeva Z, Varyasin V, Berezhnaja E, Vandysheva R, Gutyrchik N, Pechnikova V, Kontorshchikov A, Midiber K, Kakturskij L. Mikhaleva L, et al. Biomedicines. 2023 Oct 17;11(10):2811. doi: 10.3390/biomedicines11102811. Biomedicines. 2023. PMID: 37893183 Free PMC article.
SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a/C3a receptor signalling.
Perico L, Morigi M, Pezzotta A, Locatelli M, Imberti B, Corna D, Cerullo D, Benigni A, Remuzzi G. Perico L, et al. Sci Rep. 2023 Jul 14;13(1):11392. doi: 10.1038/s41598-023-38382-5. Sci Rep. 2023. PMID: 37452090 Free PMC article.
Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies.
Li Q, Chen Z, Zhou X, Li G, Zhang C, Yang Y. Li Q, et al. Front Genet. 2023 May 26;14:1187985. doi: 10.3389/fgene.2023.1187985. eCollection 2023. Front Genet. 2023. PMID: 37303950 Free PMC article. Review.
Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.
Anand A, Aoyagi H. Anand A, et al. Medicina (Kaunas). 2023 May 16;59(5):959. doi: 10.3390/medicina59050959. Medicina (Kaunas). 2023. PMID: 37241191 Free PMC article. Review.

References

1. Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, et al. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020 Feb;12((2)):244. - PMC - PubMed
1. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. doi: 10.1002/jmv.25722. - PMC - PubMed
1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Jan; doi: 10.1056/NEJMoa2001316. - PMC - PubMed
1. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [cited 2020 Mar 10] Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis....
1. Roser M, Ritchie H. Coronavirus Disease (COVID-19) Our World in Data. 2020. [cited 2020 Mar 10]. Available from: https://ourworldindata.org/coronavirus.

Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade - PubMed (original) (raw)